GlassScriptPhysician profile
Victor Anglin
NPI 1881641496
$5,174.55
in general payments reported to CMS, 2019-2025
27 companies · $214 in 2025
The $214 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,394 · 2020: $63.10 · 2021: $898 · 2022: $1,346 · 2023: $1,141 · 2024: $119 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,473.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,519.26 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $890.26 | 2019-2024 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $659.50 | 2019-2023 | Trelegy Ellipta |
| Lilly USA, LLC | $470.39 | 2019-2023 | Mounjaro, Emgality, Reyvow |
| Boehringer Ingelheim Pharmaceuticals, INC. | $182.21 | 2021-2023 | Jardiance |
| Amgen INC. | $155.08 | 2019-2023 | Otezla |
| Abbvie INC. | $140.26 | 2019-2022 | |
| Pfizer INC. | $137.40 | 2019-2023 | |
| Teva Pharmaceuticals USA, INC. | $133.36 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $126.52 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $119.91 | 2023 | Rexulti |
| Tactile Systems Technology INC | $104.57 | 2019 | |
| Novartis Pharmaceuticals Corporation | $97.30 | 2019-2023 | |
| Mylan Specialty L.P. | $72.28 | 2022-2023 | Yupelri |
| Merck Sharp & Dohme LLC | $49.07 | 2019-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $42.77 | 2023 | Cologuard Collection Kit |
| Almatica Pharma LLC | $38.04 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $35.63 | 2021 | |
| Sanofi-Aventis U.S. LLC | $34.63 | 2019 | |
| Scilex Pharmaceuticals INC. | $32.35 | 2019 | |
| Inspire Medical Systems, INC. | $28.57 | 2023 | Inspire |
| Stryker Corporation | $23.79 | 2022 | |
| Abbott Laboratories | $19.71 | 2022 | |
| Eisai INC. | $19.34 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.48 | 2021 | |
| Insulet Corporation | $14.63 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Anglin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.